Skip to Main Content

Paper Details

Phase I Trial of Anti-Vascular Endothelial Growth Factor/Anti-angiopoietin 2 Bispecific Antibody RG7716 for Neovascular Age-Related Macular Degeneration.
Ophthalmol Retina
50
2017
Author NameAffiliation
Usha ChakravarthyEye and Ear Clinic, Royal Victoria Hospital
Clare BaileyBristol Eye Hospital
Peter A CampochiaroWilmer Eye Institute, Johns Hopkins University School of Medicine
Adnan TufailMoorfields Eye Hospital
Jayashree SahniClinical Development, Roche Pharma Research and Early Development
  • 1 - 5

Datasets

Release 1.2